Cancer‐Testis Antigens in Immuno Oncology Mechanisms Therapeutic Strategies and Clinical Perspectives
Cancer‐testis antigens (CTAs) represent a unique class of tumor‐associated antigens (TAAs) with highly restricted expression in immune‐privileged tissues and widespread aberrant activation in various malignancies. Their potent immunogenicity and tumor specificity make CTAs promising targets for cancer immunotherapy. Th...